# US 2024/0004221 A1 · Ophthalmic lens with an optically non-coaxial zone for myopia control

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0004221 A1
- Document ID: US20240004221A1
- Status: Published application
- Kind: A1
- Application number: 18/368,596
- Filed: 2023-09-15
- Published: 2024-01-04
- Earliest claimed: 2021-03-09
- Assignees: Johnson & Johnson Vision Care, Inc.
- Applicants: Johnson & Johnson Vision Care, Inc.
- Inventors: Noel A. Brennan; Xu Cheng; Jaclyn V. Hernandez; Michael J. Collins; Brett A. Davis; Fan Yi; Derek Dean Nankivil
- Web page: https://patentgrep.com/patent/US20240004221A1

## CPC

- G02C 7/049: {Contact lenses having special fitting or structural features achieved by special materials or material structures}
- A61F 2/1451: {Inlays or onlays}
- A61F 2/1618: {Multifocal lenses}
- G02C 7/02: Lenses; Lens systems {; Methods of designing lenses}
- G02C 7/022: {Ophthalmic lenses having special refractive features achieved by special materials or material structures (G02C7/049 takes precedence)}
- G02C 7/04: Contact lenses for the eyes (disinfection or sterilisation of contact lenses A61L12/00)
- G02C 2202/24: Myopia progression prevention
- G02C: SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES (trial frames for testing the eyes A61B3/04; goggles or eyeshields not having the same features as spectacles A61F9/00)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The present disclosure relates to ophthalmic devices such as ophthalmic lenses. An ophthalmic device may comprise an ophthalmic lens for at least one of slowing, retarding or preventing myopia progression. The ophthalmic lens may comprise a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising an ADD power, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone.

## Claims

### Claim 1

An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression, the ophthalmic lens comprising:
a center zone with a negative power for myopic vision correction; and
at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising a positive power relative to the center zone, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone, wherein the at least one treatment zone has an annular configuration sharing a common geometric axis with the center zone, and wherein the surface shape of the at least one treatment zone causes light passing therethough to focus in front of the retina at a location that surrounds but is not coaxial with the geometric axis of the center zone.

### Claim 2 (depends on 1)

The ophthalmic lens of claim 1, wherein the portion of the generally toroidal shape may be derived from a torus (e.g., a spheroidal torus), after making a slice in the shape of the surface of a right circular cone through the surface of the spheroidal torus wherein the principal axis of the cone is coincident with the axis of rotation about which the torus is generated.

### Claim 3 (depends on 1)

The ophthalmic lens according to claim 1, wherein the at least one treatment zone is configured to minimize generation of a focal point behind a retinal plane of the eye of a wearer.

### Claim 4 (depends on 1)

The ophthalmic lens according to claim 1, further comprising a transition zone disposed between then center zone and the at least one treatment zone such that the at least one treatment zone, the transition zone, and the center zone form a continuous surface.

### Claim 5 (depends on 1)

The ophthalmic lens according to claim 1, wherein the at least one treatment zone comprises an ADD power relative to the myopia correction power of greater than +0.50 D.

### Claim 6 (depends on 1)

The ophthalmic lens according to claim 1, wherein the at least one treatment zone comprises an optical power from about −10.00 D to about +15.00 D.

### Claim 7 (depends on 1)

The ophthalmic lens according to claim 1, wherein a diameter of the center zone is about 2 mm to about 7 mm.

### Claim 8 (depends on 1)

The ophthalmic lens according to claim 1, wherein the at least one treatment zone has an outer margin at about 4.5 mm from a center of the lens.

### Claim 9 (depends on 1)

The ophthalmic lens according to claim 1, wherein a halo effect is minimized.

### Claim 10 (depends on 1)

The ophthalmic lens according to claim 1, wherein the ophthalmic lens comprises a contact lens.

### Claim 11 (depends on 1)

The ophthalmic lens according to claim 1, wherein the ophthalmic lens comprises a spectacle lens.

### Claim 12 (depends on 1)

The ophthalmic lens according to claim 1, wherein the ophthalmic lens comprises an intraocular lens, a corneal inlay, or a corneal onlay.

### Claim 13 (depends on 1)

The ophthalmic according to claim 1, further comprising one or more stabilization mechanisms.

### Claim 14

An ophthalmic lens for at least one of slowing, retarding or preventing myopia progression, the ophthalmic lens comprising:
a center zone with a negative power for myopic vision correction, the center zone having a principal axis orthogonal to a surface thereof and passing through a center of the ophthalmic lens; and
at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile comprising a positive power relative to the center zone, the at least one treatment zone having a surface shape comprising a portion of a generally toroidal shape, wherein the at least one treatment zone is arranged as to form a continuous surface with the center zone, and wherein the at least one treatment zone has a tilt angle configured to direct an innermost ray relative to a cross section of the treatment zone to cross the principal axis at a point that is at or anterior to a retinal plane of a wearer of the ophthalmic lens, wherein the at least one treatment zone has an annular configuration sharing a common geometric axis with the center zone, and wherein the surface shape of the at least one treatment zone causes light passing therethough to focus in front of the retina at a location that surrounds but is not coaxial with the geometric axis of the center zone.

### Claim 15 (depends on 14)

The ophthalmic lens according to claim 14, wherein the tilt angle is configured to direct the innermost ray to cross the principal axis at a point between the retinal plane and a point on the principal axis that represents a coincident point focus of the treatment zone.

### Claim 16 (depends on 14)

The ophthalmic lens of claim 14, wherein the portion of the generally toroidal shape may be derived from a torus (e.g., a spheroidal torus), after making a slice in the shape of the surface of a right circular cone through the surface of the spheroidal torus wherein the principal axis of the cone is coincident with the axis of rotation about which the torus is generated.

### Claim 17 (depends on 14)

The ophthalmic lens according to claim 14, further comprising a transition zone disposed between then center zone and the at least one treatment zone such that the at least one treatment zone, the transition zone, and the center zone form a continuous surface.

### Claim 18 (depends on 14)

The ophthalmic lens according to claim 14, wherein the at least one treatment zone comprises an ADD power relative to myopia correction power of greater than +5.00 D.

### Claim 19 (depends on 14)

The ophthalmic lens according to claim 14, wherein the at least one treatment zone comprises an optical power from about −10.00 D to about +15.00 D.

### Claim 20 (depends on 19)

The ophthalmic lens according to claim 19, wherein the tilt angle is dependent upon the optical power of the treatment zone.

### Claim 21 (depends on 14)

The ophthalmic lens according to claim 14, wherein a diameter of the center zone is about 3 mm to about 7 mm.

### Claim 22 (depends on 14)

The ophthalmic lens according to claim 14, wherein the at least one treatment zone has an outer margin at about 4.5 mm from a center of the lens.

### Claim 23 (depends on 14)

The ophthalmic lens according to claim 14, wherein a halo effect is minimized.

### Claim 24 (depends on 14)

The ophthalmic lens according to claim 14, wherein the ophthalmic lenses comprises a contact lens.

### Claim 25 (depends on 14)

The ophthalmic lens according to claim 14, wherein the ophthalmic lenses comprises a spectacle lens.

### Claim 26 (depends on 14)

The ophthalmic lens according to claim 14, wherein the ophthalmic lens comprises an intraocular lens, a corneal inlay, or a corneal onlay.

### Claim 27 (depends on 14)

The ophthalmic according to claim 14, further comprising one or more stabilization mechanisms.
